Approaches to sequence the HTT CAG repeat expansion and quantify repeat length variation by Ciosi, Marc et al.





Approaches to Sequence the HTT CAG
Repeat Expansion and Quantify Repeat
Length Variation
Marc Ciosia,∗, Sarah A. Cumminga, Afroditi Chatzia, Eloise Larsona, William Totteya,
Vilija Lomeikaitea, Graham Hamiltona,b, Vanessa C. Wheelerc,d, Ricardo Mouro Pintoc,d,
Seung Kwake, A. Jennifer Mortonf and Darren G. Moncktona
aInstitute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University
of Glasgow, Glasgow, UK
bGlasgow Polyomics, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
cMolecular Neurogenetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA,
USA
dDepartment of Neurology, Harvard Medical School, Boston, MA, USA
eCHDI Management/CHDI Foundation, Princeton, NJ, USA
f Department of Physiology, Development and Neuroscience, University of Cambridge, Tennis Court Road,
Cambridge, UK
Abstract.
Background: Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansion of
the HTT CAG repeat. Affected individuals inherit ≥36 repeats and longer alleles cause earlier onset, greater disease severity
and faster disease progression. The HTT CAG repeat is genetically unstable in the soma in a process that preferentially
generates somatic expansions, the proportion of which is associated with disease onset, severity and progression. Somatic
mosaicism of the HTT CAG repeat has traditionally been assessed by semi-quantitative PCR-electrophoresis approaches that
have limitations (e.g., no information about sequence variants). Genotyping-by-sequencing could allow for some of these
limitations to be overcome.
Objective: To investigate the utility of PCR sequencing to genotype large (>50 CAGs) HD alleles and to quantify the
associated somatic mosaicism.
Methods: We have applied MiSeq and PacBio sequencing to PCR products of the HTT CAG repeat in transgenic R6/2 mice
carrying ∼55, ∼110, ∼255 and ∼470 CAGs. For each of these alleles, we compared the repeat length distributions generated
for different tissues at two ages.
Results: We were able to sequence the CAG repeat full length in all samples. However, the repeat length distributions for
samples with ∼470 CAGs were biased towards shorter repeat lengths.
Conclusion: PCR sequencing can be used to sequence all the HD alleles considered, but this approach cannot be used
to estimate modal allele size or quantify somatic expansions for alleles 250 CAGs. We review the limitations of PCR
sequencing and alternative approaches that may allow the quantification of somatic contractions and very large somatic
expansions.
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INTRODUCTION
Huntington’s disease (HD) is caused by the expan-
sion of a CAG repeat in exon one of the HTT gene.
Affected individuals inherit ≥36 CAG repeats and
longer alleles are associated with earlier onset, greater
disease severity and faster disease progression [1–3].
The HTT CAG repeat is genetically unstable in the
germline, which frequently causes the number of
CAG repeats to increase in successive generations
[4]. Germline instability of the HTT CAG repeat is
thus the cause of the anticipation often seen in HD,
i.e., earlier onset and increased disease severity in
successive generations. The HTT CAG repeat is also
genetically unstable in the soma [5]. The somatic
mosaicism of the HTT CAG repeat is cell-type spe-
cific [6], expansion-biased and is dependent on both
the number of inherited CAG repeats and age [7, 8].
In HD patients and HD mouse models, the largest
somatic CAG expansions are observed in the cortex
and striatum [9–12], the brain region most affected
by HD pathology [13]. Such somatic expansions can
contain dozens, hundreds or even thousands of re-
peats and are observed early in the course of the dis-
ease [9]. Because patients with a larger number of
CAG repeats experience earlier onset, greater dis-
ease severity and faster progression, somatic CAG
expansions are likely determinants of the tissue speci-
ficity, onset, severity, and progression of the disease.
Several association studies have gathered evidence
that supports this hypothesis. Swami et al. [14] inv-
estigated somatic expansion in post-mortem DNA
samples from HD patients, and showed that patients
with particularly early-onset have a higher propor-
tion of large expansions in the cortex. Most recently,
genetic association studies in HD patient cohorts have
revealed the association between DNA repair gene
variants and age at motor signs of HD and HD pro-
gression [15–19]. These data suggest that somatic
CAG repeat expansions contribute toward HD pat-
hology. Nevertheless, it remains unknown whether
somatic expansions are required to precipitate pat-
hology, or what their relative contribution to HD
pathology is. More detailed quantitative analyses of
the dynamics of somatic mosaicism should help to
answer some of these questions, and further disentan-
gling of the mechanisms by which they are generated
should allow for the identification of additional ther-
apeutic targets. Although several components of the
DNA mismatch repair pathway have been shown to
be critical for somatic expansion [12, 20–23], the pre-
cise molecular processes that generate expansions
and determine their tissue specificity is unknown
[18, 19, 24, 25]. In this context, precise and accu-
rate quantification of HTT CAG somatic mosaicism
in patient samples and model systems is warranted,
since it may provide a suitable phenotype for genetic
association studies aimed at identifying genetic
variants that act as modifiers of repeat instability [7,
15]. Somatic mosaicism in HD patients and model
organisms is traditionally assessed by gel or capil-
lary electrophoresis of single-molecule, small pool
(SP) or bulk-PCR (PCR using thousands of DNA
molecules as a template) products [26]. However,
using electrophoresis to estimate the number of re-
peats in the PCR fragments detected does not pro-
vide any information about genetic variants within
and around the HTT CAG repeat, which can lead to
erroneous electrophoresis estimates of the number of
pure CAG repeats [7]. Massively parallel sequencing
(MPS) should allow for some of the limitations of
electrophoresis to be overcome. However, although
short MPS reads (<150 nt) can be used to genotype
variants within and around the HTT CAG repeat,
longer reads (≥150 bp) are required to be able to
phase these variants with the CAG repeat. Identify-
ing these variants and phasing them with the CAG
repeat is essential to determine pure CAG length in
HD patients and because some of them (e.g., presence
or absence of the CAACAG hexamer 3’ of the CAG
repeat) are associated with variation in HD onset [7,
16, 27], severity and progression [7].
Indeed, MPS has also recently proven useful for
the detection of microsatellite somatic mosaicism in
tumour samples [28, 29]. At high read-depth, MPS
data should allow precise and accurate quantifica-
tion of somatic repeat length variants, whilst also pro-
viding information about genetic variants within and
around the repeat. However, massively parallel seq-
uencing is not commonly used to sequence, size and
quantify the somatic mosaicism associated with trin-
ucleotide expansions. The main reason for this is that
sequencing reads generated by commonly used MPS
platforms (<150 nt) are too short for the accurate
sizing of the repeat, which requires repeat-spanning
sequencing reads. However, long-read sequencing
platforms have recently been successfully applied to
the sequencing of trinucleotide repeat expansions.
Using PacBio single-molecule real-time (SMRT)
long-read sequencing, Cumming et al. [30] have
demonstrated the usefulness of bulk-PCR sequencing
to sequence myotonic dystrophy type 1 (DM1)-assoc-
iated DMPK CTG repeat expansions with modal alle-
les of up to ∼400 CTG repeats. Besides, Hafford-Tear
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et al. [31] have sequenced Fuchs endothelial corneal
dystrophy-associated TCF4 CTG repeat expansions
with modal alleles of up to ∼150 CTG repeats and
some associated somatic expansions of more than
1,000 repeats, using an amplification-free PacBio
SMRT approach. As demonstrated by Ciosi et al. [7]
using 400 nt MiSeq reads for sequencing of the HTT
CAG repeat, PacBio SMRT long-read sequencing
is not required for the sequencing and quantifica-
tion of somatic mosaicism of shorter trinucleotide
repeat expansions. This is likely to apply to several
other polyglutamine encoding CAG repeat disorders
which are typically associated with smaller repeat
expansions (<80 CAG repeats) and for which prelim-
inary evidence also suggest somatic expansion may
be important [32].
Although MPS approaches allow some of the
limitations of electrophoresis to be overcome by pro-
viding information about genetic variants within and
around the repeat, they might be limited in their
ability to detect very large repeat expansions. How-
ever, no formal comparison of electrophoresis and
MPS approaches for the quantification of somatic
mosaicism of trinucleotide expansions has previously
been presented. In this study, we have applied bulk-
PCR sequencing approaches using Illumina MiSeq
and PacBio SMRT long-read sequencing to assess
their usefulness for the estimation of the modal allele,
and the quantification of somatic expansions, associ-
ated with small (∼50 to ∼100 CAG) and large (∼100
to ∼500 CAG) HTT repeat expansions. Where appro-
priate, the bulk-PCR sequencing data were compared
with more traditional small pool-PCR (SP-PCR)
Southern blot analyses and capillary electrophoresis
of fluorochrome-labelled bulk-PCR products.
MATERIALS AND METHODS
Samples
In order to evaluate the ability of bulk-PCR seq-
uencing approaches to sequence different numbers of
CAGs, we used previously described [33] DNA sam-
ples from an allelic series of R6/2 transgenic mice
[34] carrying a single copy of a human HTT trans-
gene with germline alleles containing ∼55, ∼110,
∼255 or ∼470 CAGs [33, 35] (Table 1). To mea-
sure different levels of somatic mosaicism of the HTT
CAG repeat, DNA samples isolated from four dif-
ferent tissues, known to harbour different levels of
somatic mosaicism, were selected (striatum, liver,
cortex and cerebellum, Table 1). To capture some
of the age-dependent increase in somatic mosaicism,
we analysed samples from one young and one old
mouse for each repeat length, aiming at analysing
DNA from the oldest available mice. The life span of
R6/2 mice carrying 100 to 300 CAGs is much shorter
than in mice carrying < 60 and >440 CAGs [35–37].
The oldest available mice carrying ∼110 and ∼255
CAGs were therefore much younger (∼5 months old),
than the oldest mice carrying ∼55 and ∼470 CAGs
(Table 1). To ensure that somatic mosaicism did not
bias the estimation of the number of CAGs in the pro-
genitor allele, a DNA sample of the tail at weaning
was also analysed for each of the older mice (Table 1).
MiSeq library preparation for four R6/2 mice
inheriting HTT transgenes with ∼55 or ∼110
CAGs
The HTT exon one trinucleotide repeat (compr-
ising the CAG repeat, a CAACAG hexamer, a CCG
CCA hexamer, the CCG repeat and the CCT repeat)
was PCR-amplified from 20 ng of genomic DNA
using MiSeq-compatible PCR primers [38]. The
HTT-specific part of these MiSeq-compatible PCR
primers corresponded to the primer pair 31329/33934
[34] that targets the human HHTT exon one trinu-
cleotide repeat from the R6/2 human HTT transgene
and not the endogenous mouse Htt CAG repeat. A
single PCR per tissue was performed. Each sample,
i.e., one tissue from a particular mouse, was associ-
ated with a unique pair of indexes, also frequently
referred to as a sample barcode. TruSeq CD indexes
were used for the samples with ∼55 CAGs, and
Nextera XT Index Kit v2 indexes were used for the
samples with ∼110 CAGs (Supplementary Tables 1
and 2) [38]. MiSeq sequencing was performed with a
400 nt forward read and a 200 nt reverse read by Glas-
gow Polyomics (https://www.polyomics.gla.ac.uk).
See Ciosi et al. [38] for the full details of the sequenc-
ing library preparation and MiSeq sequencing.
Preparation of bulk-PCR products for PacBio
SMRT sequencing
Bulk-PCR products of the HTT exon one trinucl-
eotide repeat (comprising the CAG repeat, a CAA
CAG hexamer, a CCGCCA hexamer, the CCG re-
peat and the CCT repeat) for PacBio SMRT library
preparation were generated by PCR using barcoded
PCR primers. PacBio barcodes for the PacBio RS
II System in symmetric mode [39] were used as 5’-
tails to the R6/2 transgene-specific primers MS1F
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Table 1
Characteristics of the R6/2 DNA samples analysed
PacBio Number Age Striatum Liver Cortex Cerebellum Tail at Tail at
sequencing of CAGs∗ (weeks) death weaning
batch/run
1 53 6 + + + + + –
1 53 117 + + + + – +
1 109 4.4 + + + + – –
1 111 20 + + + + – +
2 252 6 + + + + – –
1 & 2 258 20 + + + + – +
2 469 6 + + + + – –
2 476 115.7 + + + + – –




cifically target the human HHTT exon one (which
contains the CAG repeat) from the R6/2 transgene and
not the endogenous mouse Htt CAG repeat (see Sup-
plementary Table 3 for the full sequence of barcoded
primers used). PCRs using the barcoded primers
MS1F and MS1R should generate PCR products
of 557, 722, 1157 and 1802 bp on R6/2 transgene
templates containing 55, 110, 255, or 470 CAGs
respectively. Each sample, i.e., one tissue from a
particular mouse, was associated with a unique bar-
code. Fifteen microliter PCRs containing 20 ng of
genomic DNA were set up as described by Ciosi et al.
[38] using the following cycling conditions: (96◦C,
5 min); 28 cycles of (96◦C, 45 s), (59◦C, 45 s) and
(72◦C, 3 min); and (72◦C, 10 min).
Samples were processed in two batches, depend-
ing on the number of CAGs in the modal allele, with
the aim to sequence the two batches on two separate
PacBio RSII SMRT cells. This precaution was taken
because fragment loading on PacBio RSII SMRT
cells was known to be biased towards the loading
of smaller molecules. The first batch corresponded
to the samples with ∼55 and ∼110 CAGs, and the
second batch corresponded to samples with ∼255
and ∼470 CAGs. One DNA sample, from the tail at
weaning of the 20-week-old mouse with 258 CAGs
(Table 1), was included in both batches to allow eval-
uation of potential inter-SMRT cell heterogeneity in
sequencing quality.
The first batch of PCR products corresponded to
the R6/2 samples with the shorter modal alleles (four
or five tissues for each of the four mice with ∼55 or
∼110 CAGs, Table 1). For this first batch, five PCRs
were performed (as described above) for each sample
(i.e., tissue from a particular mouse). After ampli-
fication, the PCR products were pooled to obtain
one pool of ∼70 l per sample. A 15 l aliquot of
each of these sample-specific pools of PCR prod-
ucts was resolved on a 1.5% agarose gel to confirm
amplification. The remaining PCR products (∼55 l
per sample) corresponding to the same number of
CAGs were pooled (one pool for ∼55 CAGs, one
pool for ∼110 CAGs and one pool for ∼255 CAGs)
and purified using a 1.4X AMPure® XP (Beckman
Coulter) clean-up procedure [38] with a final elution
volume equal to 1/4 the volume of beads used. The
quality of the three PCR product pools (∼55, ∼110
and ∼255) post-AMPure purification was assessed
by capillary electrophoresis on a Bioanalyzer (Agi-
lent) to check that the fragments had the expected size
and that primer dimers were absent. These three pools
(∼55, ∼110 and ∼255 CAGs) were then combined
to form an equimolar pool (i.e., the same number
of molecules per sample based on Bioanalyzer-es-
timated molarity), containing ≥500 ng of PCR prod-
uct at ≥13 ng l−1 as required by the PacBio RSII
sequencing facility at the Earlham Institute (Norwich,
UK – https://www.earlham.ac.uk).
The second batch of PCR products corresponded to
the R6/2 samples with the longer modal alleles (four
or five tissues for each of the four mice with ∼255 and
∼470 CAGs, Table 1). Five PCRs were performed (as
described above) for each sample (i.e., tissue from a
particular mouse) with ∼255 CAGs. After amplifi-
cation, the PCR products were pooled to obtain one
pool of ∼70 l per sample. A 7.5 l aliquot of each
of these sample-specific pools of PCR products was
resolved on a 1.5% agarose gel to confirm ampli-
fication. The remaining PCR products (∼60 l per
sample) were then pooled and purified using the 1.4X
AMPure® XP clean-up procedure described above.
The quality of the pool of ∼255 CAGs PCR prod-
ucts was then assessed on a Bioanalyzer (Agilent) as
described above.
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Eight to 60 PCRs were performed (as described
above) for each sample with ∼470 CAGs depend-
ing on PCR yield (i.e., more PCRs were performed
for samples associated with lower PCR yield). After
amplification, the PCR products were pooled to
obtain one pool per sample. Each of these pools was
purified using a 0.6X AMPure® XP clean-up proce-
dure [38] with a final elution volume equal to 1/2 the
volume of beads used. This lower amount of 0.6X
AMPure® XP beads, relative to the amount used for
the samples with ∼55, ∼110 and ∼255 CAGs, was
used for the samples with ∼470 CAGs in an attempt
to remove smaller fragments that would, if present, be
preferentially sequenced. The quality and quantity of
each of these PCR product pools were then assessed
on a Bioanalyzer (Agilent) as described above. The
pools of ∼470 CAGs PCR products were then com-
bined with the pool of ∼255 CAGs PCR products to
form an equimolar pool (same number of molecules
per sample based on Bioanalyzer-estimated mol-
arity). The equimolar pool was then concentrated
using a 1.6X AMPure® XP clean-up procedure to
obtain a solution containing ≥500 ng of PCR prod-
uct at ≥13 ng l−1 as required by the PacBio RSII
sequencing facility at the Earlham Institute (Norwich,
UK).
The 500 ng PCR product pools from batch one
and two were sent separately to the Earlham Institute
(Norwich, UK) for PacBio RSII library preparation
and sequencing on one SMRT cell per batch. Mag-
bead loading, 150,000 zero-mode waveguides per
SMRT cell and the C4-P6 chemistry were used for
the PacBio RSII SMRT sequencing. Circular consen-
sus sequencing (CCS) reads (the consensus sequence
resulting from the alignment between subreads obt-
ained from a single DNA molecule [40]) were pro-
duced from the raw PacBio subreads using the SMRT
Portal’ RS ReadsOfInsert protocol (settings used:
Minimum Full Passes = 2; Minimum Predicted Accu-
racy = 90%; Minimum Length of Reads of Insert (In
Bases) = 500; Maximum Length of Reads of Insert
(In Bases) = 9,000). Demultiplexing of the PacBio
reads was carried out as part of the same protocol
(Minimum Barcode Score = 23, which is equivalent
to 99.5% calling accuracy [39]) to obtain a fastq file
containing CCS reads for each sample.
Estimation of the percentage of on-target and
full-length reads for each experiment
The percentage of on-target and full-length reads
for each experiment (i.e., a particular number of
CAGs sequenced on a particular sequencing plat-
form) was estimated for one representative sample
per experiment (the cerebellum of the older mice)
by subsequently aligning the sequencing reads to
reference sequences corresponding to the 5’-flank
plus CAGs, the 3’-flank plus CAGs, or only to a
CAG repeat (See Supplementary File 1 for more
details). Reads aligned to both flanks were consid-
ered full-length. Reads aligned to at least one of the
flanks or the pure CAG repeat reference sequence
were considered on-target but not full-length. Reads
that did not align to either flank or to the pure
CAG repeat reference sequence, were considered
off-target. Assuming that the most likely source of
off-target reads would be non-specific PCR of mouse
DNA, the most likely source of the off-target reads
was determined using Blastn [41] against all Mus
musculus sequences available in NCBI Nucleotide
collection (nr/nt) [42]. If no Mus musculus match
was obtained, we attempted to determine the most
likely source of the off-target reads using Blastn [41]
against all sequences available in NCBI Nucleotide
collection (nr/nt) [42]. These analyses revealed: i)
that nearly all reads (>99.4%) in each experiment
were on-target; ii) that most reads (>66.6%) were full
length, except for the MiSeq sequencing of the sample
with ∼110 CAGs; and, iii) that most of the very rare
off-target reads (<0.6%) were derived from primer-
dimers in the MiSeq experiments, and non-specific
amplification of the mouse Foxe1 locus in the PacBio
experiments (Supplementary File 1).
Genotyping of HTT alleles by aligning the
sequencing reads to synthetic reference
sequences
The sequencing reads obtained were processed on
the Galaxy instance of the University of Glasgow
(https://heighliner.cvr.gla.ac.uk) [43] using an align-
ment-based approach. Before alignment, Illumina
sequencing adapters were trimmed from the 3’-end
of the single-end forward (R1) MiSeq reads. Both
types of reads (single-end forward (R1) MiSeq re-
ads or PacBio CCS reads) were then aligned using
BWA-MEM [44] to multiple synthetic reference seq-
uences each containing a different number of CAGs.
To facilitate alignment of each sequencing read to the
reference sequence with the same number of CAG
repeats, BWA-MEM alignment parameters were
modified to use a mismatch cost markedly lower than
gap-related costs [45]. This gives greater weight to
58 M. Ciosi et al. / Sequencing of HTT CAG Expansions
the alignment of each read to the reference sequence
containing the most similar number of CAGs and
less weight to base-base mismatches not related to
CAG length variation. The default BWA-MEM para-
meters were used, except for three parameters that
were set as follows: penalty for a mismatch = 1; and,
gap open penalties = 2,2; gap extension penalties =
2,2. Synthetic reference sequences were designed
to include sequences flanking the HTT repeat up to
the binding site of the PCR primers used. For the
MiSeq read alignments, the longest synthetic ref-
erence sequence considered contained 123 CAGs
as it is the maximum theoretical number of CAGs
that could have been sequenced using the primer
pair 31329/33934 and 400 nt MiSeq reads. For the
alignment of the PacBio CCS reads obtained for the
R6/2 samples with ∼55 and ∼110 CAGs, the longest
synthetic reference sequence considered contained
200 CAGs. For the PacBio CCS reads obtained for
the R6/2 samples with ∼255 and ∼470 CAGs, the
longest synthetic reference sequence considered con-
tained 600 CAGs. Post alignment, we discarded reads
with a MAPQ score of 0 (obtained for reads aligned
equally well to >1 reference sequence) and/or reads
associated with an alignment that did not start in
the 5’-flanking sequence of the CAG repeat. The
higher the number of sequencing errors and the
number of reference sequences considered for the
alignment, the higher the probability of a sequenc-
ing read being aligned equally well to more than one
of the synthetic reference sequences considered (i.e.,
MAPQ score = 0). Higher numbers of CAG repeats,
and sequencing platforms associated with more seq-
uencing errors, are thus expected to be associated
with a higher proportion of discarded reads post align-
ment. The number of reads aligned to each reference
sequence, after discarding the aforementioned reads,
was used to generate a CAG length frequency dis-
tribution. The Galaxy workflow used is available
at https://www.myexperiment.org/workflows/5147.
html. Alignments of MiSeq reads to synthetic refer-
ences containing ≥[(modal allele)+5 CAGs] were
visually inspected in Tablet 1.19.09.03 [46] to con-
firm whether they corresponded to alignments over
the full length of the CAG repeat in the synthetic ref-
erence. All alignments of PacBio CCS reads were
inspected in this way. PacBio CCS reads stopping
within the CAG repeat or containing two concate-
nated copies of the HTT repeat (probably originating
from the concatenation of two PCR products dur-
ing the ligation of the adapters in the PacBio library
preparation) were discarded. The number of CAGs
was manually assigned to a sequencing read if the
read was aligned to a reference sequence with at least
one gap >2 nt within the CAG repeat.
PCR-capillary electrophoresis for the two R6/2
mice carrying ∼55 HTT CAG repeats
The HTT exon one repeat was PCR-amplified from
80 ng of genomic DNA using a previously described
[47] human-specific PCR assay that amplifies the
HTT CAG repeat from the R6/2 transgene with-
out amplifying the mouse Htt CAG repeat. Three
independent PCRs were performed per sample (i.e.,
tissue from each of the two R6/2 mice carrying ∼55
HTT CAG repeats). The forward primer was fluo-
rescently labelled with 6-FAM and PCR products
were resolved using the ABI 3730xl DNA analyzer
(Applied Biosystems) with GeneScan 500 LIZ as
internal size standard (Applied Biosystems). Gen-
eMapper v3.7 (Applied Biosystems) was used to
generate CAG repeat size distribution traces. Peaks
falling below the threshold of intensity, 50 fluores-
cent units, were excluded from the analysis. The final
CAG frequency distribution considered for each sam-
ple was the mean distribution over the three obtained
for each sample, i.e., one per PCR.
Small pool-PCR
Previous small-pool PCR (SP-PCR) experiments
using the striatum from the 117-week-old R6/2 mo-
use with ∼55 CAGs showed that a small percent-
age of somatic CAG expansions are very large (>90
CAGs) [33]. It is not clear if these very large somatic
CAG expansions can also be detected by capillary
electrophoresis or either of the parallel-sequencing
approaches in combination with bulk-PCR. To inves-
tigate this, we used SP-PCR to quantify these very
large CAG expansions in the striatum sample of the
R6/2 mouse with ∼55 CAGs. The SP-PCR quan-
tification involved a combination of single-molecule
PCRs (to derive the overall length distribution and
precisely quantify the amount of input DNA) and
PCRs using higher template concentrations (to esti-
mate the frequency of the rarer large repeat length
increases) [48]. A concentration range experiment
between 5 and 50 pg of template DNA per PCR was
first conducted to establish the correct quantity of
template DNA to achieve single-molecule PCRs and
17.5 pg per PCR was selected. Overall, 288 PCRs
with 17.5 pg (single molecule level), 132 with 150 pg,
and 44 with 250 pg of genomic DNA template as
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starting material, were performed as previously
described [33]. The PCR products obtained were
resolved by agarose gel electrophoresis, Southern
blotted and hybridised as previously described [33].
Individual bands (>250 CAG) were identified and
sized by comparing against the 1 Kb Plus DNA Lad-
der (Invitrogen) using the CLIQS 1D gel analysis
software (TotalLabs, UK). Assuming the number of
bands is proportional to the amount of template,
the 17.5 pg data were used to calculate expected
bands/lane at 150 pg under assumptions of a Pois-
son distribution [48] and the frequency of very long
expansions in the 150 pg PCR products was deter-
mined.
Data availability
The sequencing reads for this study have been
deposited in the European Nucleotide Archive (ENA)




Qualitative assessment of the usefulness of
MiSeq and PacBio SMRT sequencing to quantify
somatic mosaicism in R6/2 mice with ∼55 CAGs
and comparison with capillary electrophoresis
For each organ analysed, regardless of the method
used to size the number of CAGs in the PCR pro-
ducts (capillary electrophoresis, MiSeq or PacBio se-
quencing) we could identify a mode of the CAG fre-
quency distribution ∼55 CAGs (Fig. 1). These esti-
mates are in the same range as those previously
estimated by SP-PCR Southern blot and bulk-PCR
capillary electrophoresis (Table 1) [33]. The percen-
tage of MiSeq reads that uniquely aligned to a syn-
thetic reference sequence (i.e., reads not discarded
post alignment) was very high for both young and old
mice with ∼55 CAGs (96.5% and 96.15% on average
for the 6-week-old and the 117-week-old mouse
respectively). These percentages were slightly lower
for both mice for the PacBio CCS reads (80.91%
and 81.20% on average for the 6-week-old and the
117-week-old mouse respectively). These lower
percentages for the PacBio CCS reads might be exp-
lained by the fact that sequencing errors are more
frequent in PacBio CCS reads (Fig. 2C and Supple-
mentary Figure 1) than MiSeq reads (Fig. 2A and
Supplementary Figure 1), and the fact that more
reference sequences were considered for the PacBio
CCS reads (200 and 123 reference sequences
were considered for the PacBio CCS and MiSeq
reads respectively – see above). Indeed, a higher
number of sequencing errors and of reference
sequences considered both increase the likelihood
for a sequencing read to be aligned equally well to
two or more reference sequences and therefore to
be discarded post-alignment. It was very clear from
all the MiSeq forward alignments, as well as from
all the PacBio CCS reads alignments, that all the
mice with ∼55 CAGs carried an HTT allele with a
pure CAG tract, seven CCGs and a typical HTT all-
ele structure, i.e., an HTT allele of structure (CAG)n
(CAACAG)1(CCGCCA)1(CCG)7(CCT)2 [7]. This
allele structure could also be confirmed by alig-
ning the reverse MiSeq reads to the synthetic ref-
erence sequence (CAG)100(CAACAG)1(CCGCCA)1
(CCG)7(CCT)2-3’-flank (Supplementary Figure 2).
A qualitative assessment of somatic mosaicism in
the different tissues of the two mice analysed can be
performed by comparing the CAG frequency distri-
butions obtained. The CAG frequency distributions
obtained for different tissues in the 117-week-old
mouse should be interpreted relative to the inherited
progenitor allele which corresponds to the modal
number of CAGs in the tail at weaning (Fig. 1). For all
three approaches (capillary electrophoresis, MiSeq
or PacBio sequencing), the CAG frequency distri-
butions obtained reflect the expected age-dependent
and tissue-specific nature of HTT CAG somatic
mosaicism [33]. Indeed, variation in the number of
CAGs was higher in the 117-week-old mouse than
the 6-week-old one and was higher in the striatum
than in the other tissues in the 117-week-old mouse
(Fig. 1). Over the range 55 to 80 repeats, almost
identical CAG frequency distributions were obtained
with MiSeq and capillary electrophoresis (Fig. 1).
The CAG frequency distributions obtained from the
PacBio CCS reads were broadly similar to the ones
obtained by MiSeq and capillary electrophoresis
but were generally broader around the mode. This
might be because PacBio subreads contain many
indels (Fig. 2 and Supplementary Figure 1) which,
in turn, leads to an inaccurate number of CAGs in
the PacBio CCS reads (which are produced by the
alignment between subreads obtained from a single
DNA molecule [40]). Even though the percentage
of uniquely aligned PacBio CCS reads (i.e., reads
not discarded post alignment) was high (>76%) for
all samples with ∼55 CAGs, the CAG frequency
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Fig. 1. Qualitative assessment of somatic mosaicism comparing CAG frequency distributions obtained by capillary electrophoresis, MiSeq
or PacBio SMRT sequencing of bulk-PCR products obtained for different tissues of one 6-week-old and one 117-week-old R6/2 mouse with
∼55 CAGs. Capillary electrophoresis data in black, MiSeq sequencing data in white and PacBio SMRT sequencing data in grey.
distributions obtained with these reads contained
only 382 CCS reads on average (Fig. 1). The com-
parison with capillary electrophoresis and MiSeq
sequencing demonstrates that this low number of
CCS reads is associated with a high sampling error
of somatic variants. Indeed, the CAG frequency
distributions obtained with the PacBio CCS reads
were very discontinuous, while they were very
smooth with capillary electrophoresis and MiSeq
sequencing (Fig. 1). These jagged discontinuous
distributions still allow us to observe that there are
more somatic expansions in cortex and liver than in
the cerebellum (Fig. 1) but could lead to inaccurate
estimates of the absolute frequency of these somatic
expansions.
Comparison of three bulk-PCR approaches with
SP-PCR on the 117-week-old striatum sample
with ∼55 CAGs
As previously shown [33], SP-PCR revealed a high
frequency of somatic expansions in the striatum of the
117-week-old R6/2 mouse with ∼55 CAGs (Fig. 3A).
Most of these somatic expansions can be seen on the
autoradiographs as bands between 55 CAGs (i.e., size
of the modal allele) and 70 CAGs (Fig. 3A). SP-PCR
also detected frequent somatic expansions with 70 to
80 CAGs, and rarer somatic expansion ≥80 CAGs
(Fig. 3A). The frequency of somatic expansions ≥70
CAGs detected by SP-PCR was estimated by geno-
typing ∼1,300 molecules across 464 SP-PCRs. This
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Fig. 2. Representative sequence alignments of the 400 nt MiSeq reads (A and B), PacBio CCS reads (C and D) and PacBio subreads (E
and F) uniquely aligned (i.e., reads not discarded post alignment) to a synthetic reference sequence with 115 CAGs. Alignments shown
correspond to 30 sequencing reads obtained from the tail at weaning of the 20-week-old mouse with ∼110 CAGs. The part of the alignment
shown corresponds to the four nucleotides in the immediate 5’–flank of the HTT CAG repeat, followed by the first 20 CAGs (A, C and E),
as well as the last 7 CAGs followed by (CAACAG)1(CCGCCA)1(CCG)7(CCT)2 and the four nucleotides in the immediate 3’-flank of that
sequence (B, D and F). Note that the last nucleotide sequenced for the sample with the 400 nt MiSeq reads end was the first C of the seventh
CCG (B). The white box on the right-hand side of panel B represents the part of the PCR products containing 115 CAGs that could not be
sequenced using 400 nt MiSeq reads.
allowed a quantitative comparison between SP-PCR
and the three bulk-PCR approaches presented here
(capillary electrophoresis, MiSeq and PacBio SMRT)
that demonstrates that large expansions are better
detected by SP-PCR. The percentage of somatic
expansions with 70 to 80 CAGs was similar for the
three bulk-PCR approaches (∼4.5%, Figs. 1 and 3B)
and lower than the one estimated by SP-PCR (∼6%,
Fig. 3B). Similar percentages of somatic expansions
with 80 to 89 CAGs were detected by bulk or SP-
PCR (∼1%, Fig. 3B). No somatic expansions ≥90
CAGs were detected by bulk-PCR PacBio SMRT
sequencing (Fig. 3B, C). The percentage of somatic
expansions with 90 to 99 CAGs estimated by SP-
PCR (0.38%, Fig. 3B, C) was one order of magnitude
higher than that estimated by bulk-PCR capillary
electrophoresis and MiSeq (0.02% and 0.04% respec-
tively, Fig. 3B, C). No somatic expansions ≥100
CAGs were detected by capillary electrophoresis and
the percentage of such somatic expansion estimated
by SP-PCR (0.61%, Fig. 3B, C) was one order of mag-
nitude higher than that estimated by bulk-PCR MiSeq
(0.04%, Fig. 3B). Read depth must be considered
when directly comparing the results obtained by bulk-
PCR PacBio SMRT sequencing and bulk-PCR MiSeq
sequencing. For example, the much lower number
of PacBio CCS reads obtained for the samples with
∼55 CAGs (Fig. 1) is a very likely explanation
why somatic expansion with >90 CAGs could be
detected with 23,064 MiSeq reads for the striatum
with 55 CAGs, but not with 444 CCS PacBio reads
(Fig. 3B, C).
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Fig. 3. SP-PCR can detect very large HTT CAG somatic expan-
sions (≥90 CAGs) that cannot be detected using bulk-PCR
approaches. A) Representative small pool PCR autoradiograph
from 150 pg template DNA obtained for the striatum of the 117-
week-old R6/2 mouse with ∼55 CAGs. The number of CAG
repeats, equivalent to each molecular weight marker (left) and
the boundaries of the categories represented in panel A (right),
is indicated. The boundaries of the categories represented in panel
A (right) are also indicated by white dashed lines. B) Percentage
of large (≥70 CAGs) HTT CAG somatic expansions detected by
SP-PCR (black to white gradient), or bulk-PCR capillary elec-
trophoresis (black), bulk-PCR MiSeq (white), bulk-PCR PacBio
SMRT (grey) in the striatum of the 117-week-old R6/2 mouse with
progenitor allele ∼55 CAGs. C: HTT CAG somatic expansions
>90 CAGs from panel B. Error bars indicate the 95% confidence
intervals (they could not be estimated for the bulk-PCR capillary
electrophoresis because the fluorescence units measured cannot be
transformed into a count of PCR products detected).
Qualitative assessment of the usefulness of
MiSeq and PacBio SMRT sequencing to quantify
somatic mosaicism in R6/2 mice with ∼110
CAGs
The percentage of MiSeq reads uniquely aligned
to a synthetic reference sequence (i.e., reads not dis-
carded post alignment) for samples from mice with
∼110 CAGs was much lower (24.99% and 22.10%
on average for the 4-week-old and the 20-week-old
mouse respectively) than observed the mice with ∼55
repeats. This is most likely due to the high frequency
of sequencing errors at the end of the CAG repeat in
400 nt MiSeq reads containing ∼110 CAGs (Fig. 2B).
These sequencing errors are probably caused by the
fact that the base calling accuracy drops sharply at the
end of the MiSeq reads, with the sharp drop in base
calling accuracy happening downstream of the CAG
repeat for reads with <60 CAGs and within the end
of the CAG repeat for reads with ≥60 CAGs (Sup-
plementary Figure 3). The percentage of uniquely
aligned PacBio CCS reads (i.e., reads not discarded
post alignment) was much higher than that of MiSeq
reads and similar for samples from both mice with
∼110 CAGs (71.77% and 66.50% on average for
the 4-week-old and the 20-week-old mouse respec-
tively for the PacBio CCS reads). The mode of the
CAG frequency distribution obtained with PacBio
CCS reads for the liver of the 20-week-old mouse
was bimodal with a mode at ∼117 CAGs (like the
progenitor allele identified in the tail at weaning) and
a mode at ∼130 CAGs (Fig. 4). We could identify
a mode of the CAG frequency distributions between
110 and 120 CAGs for all the other organs analysed
with both MiSeq and PacBio data (Fig. 4). These esti-
mates are in the same range as the ones previously
estimated by SP-PCR Southern blot and bulk-PCR
capillary electrophoresis (Table 1) [33]. However, it
must be noted that the mode of the CAG distributions
obtained using the MiSeq read was ∼5 CAGs smaller
than the ones obtained using the PacBio CCS reads.
Given the amount of somatic mosaicism in the sam-
ples analysed (as illustrated by the CAG frequency
distributions obtained using the PacBio CCS reads),
we would have expected a large proportion of the
MiSeq reads to align to references sequences with
≥120 CAGs. In particular, all reads containing ≥123
CAGs should have aligned to the reference sequence
containing 123 CAGs, the theoretical maximum num-
ber of CAGs that could have been sequenced with
the PCR primer pair used and a 400 nt MiSeq read.
However, only a small proportion of the MiSeq reads
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Fig. 4. CAG frequency distributions obtained by MiSeq or PacBio SMRT sequencing of bulk-PCR products obtained for different tissues of
one 6-week-old and one 117-week-old R6/2 mouse with ∼110 CAGs. MiSeq sequencing data in white and PacBio SMRT sequencing data
in grey. The dotted line on the MiSeq sequencing data panels indicates 123 CAGs, which is the theoretical maximum number of CAGs that
could have been sequenced using the PCR primer pair (31329/33934) and a 400 nt MiSeq read.
aligned to references sequences with ≥120 CAGs.
Together with the low percentage of MiSeq reads
aligned (∼23%) and the high frequency of sequenc-
ing errors at the end of the 400 nt MiSeq reads, this
illustrates that the CAG length frequency distribu-
tions obtained for the samples from mice with ∼110
CAGs using MiSeq (Fig. 4) cannot be relied upon for
the estimation of modal allele sizes or the quantifi-
cation of somatic expansions. The maximum number
of CAGs that can reliably be sequenced using 400 nt
MiSeq reads probably lies ∼115 CAGs.
It was very clear from all the PacBio CCS re-
ads alignments that all mice with ∼110 CAGs car-
ried a typical HTT allele with a pure CAG tract and
seven CCGs (i.e., HTT allele of structure (CAG)n
(CAACAG)1(CCGCCA)1(CCG)7(CCT)2 [7]). Alth-
ough it was clear from the forward MiSeq read ali-
gnment (Fig. 2A, B) that the CAG tract was pure, the
many sequencing errors at the ends of these reads
(Fig. 2B) did not allow us to confidently determine
the allele structure. However, it was possible to det-
ermine the allele structure by aligning the reverse
MiSeq reads to the synthetic reference sequence
(CAG)100(CAACAG)1(CCGCCA)1(CCG)7(CCT)2-
3’-flank (Supplementary Figure 2).
As previously illustrated for the mice with ∼55
CAGs, a qualitative assessment of somatic mosaicism
in the different tissues of the two mice analysed
should be possible by comparing the CAG frequency
distributions obtained. The CAG frequency distribu-
tions obtained for different tissues in the 20-week-old
mouse should be interpreted relative to the progeni-
tor allele which corresponds to the modal number of
CAGs in the tail at weaning (Fig. 4). The CAG fre-
quency distributions obtained with the PacBio CCS
reads reflect the expected age-dependent and tissue-
specific nature of HTT CAG somatic mosaicism [33].
Indeed, the variation of the number of CAGs in the
PacBio data was higher in the old mouse than the
young one, and was higher in the striatum than in
the other tissues in the old mouse (Fig. 4). However,
the CAG frequency distributions obtained with the
PacBio CCS reads were very jagged and discontinu-
ous (Fig. 4). These jagged discontinuous distributions
still allowed us to observe that there are more somatic
expansions in cortex and liver than in the cerebellum
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(Fig. 4), but could lead to inaccurate estimates of
the frequency of these somatic expansions. On the
contrary, the MiSeq data failed to capture any of the
expected age-dependent and tissue-specific variation
in somatic mosaicism of the HTT CAG repeat (Fig. 4).
Qualitative assessment of the usefulness of
PacBio sequencing to quantify somatic
mosaicism in R6/2 mice with ∼255 CAGs
PCR products for one sample, the cerebellum of
the 6-week-old mouse with ∼255 CAGs, were gen-
erated and sequenced independently in each of the
two PacBio RSII runs performed. For that sample,
the percentage of PacBio CCS reads that could be
aligned to synthetic reference sequences was higher
in PacBio run one than for PacBio run two (28.45%
and 4.96%). This is likely a consequence of the
fact that the sequencing quality from the second
PacBio run was lower (Supplementary File 2). The
percentage of PacBio CCS reads aligned to a syn-
thetic reference sequence was similar for samples
from both mice with ∼255 CAGs (4.76% and 4.65%
on average for the 6-week-old and the 20-week-old
mouse respectively). No clear mode could be iden-
tified in the CAG frequency distribution obtained
for the liver of the 20-week-old mouse. For all the
other organs analysed, we could identify a mode
of the CAG frequency distribution of ∼270 CAGs
(Fig. 5). These estimates are in the same range as
the ones previously estimated by SP-PCR Southern
blot and bulk-PCR capillary electrophoresis (Table 1)
[33]. It was very clear from all the PacBio CCS read
alignments that both mice with ∼255 CAGs carried
a typical HTT allele with a pure CAG tract and
seven CCGs (i.e., HTT allele of structure (CAG)n
(CAACAG)1(CCGCCA)1(CCG)7(CCT)2 [7]). The
CAG frequency distributions obtained for the mouse
samples with ∼255 CAGs with the PacBio CCS re-
ads broadly reflect the expected age-dependent and
tissue-specific nature of the HTT CAG somatic mos-
aicism [33]. Indeed, the variation of the number of
CAGs in the PacBio data was higher in the 20-week-
old mouse than the 4-week-old, and was higher in
the striatum than in the other tissues in the old mouse
(Fig. 5). However, due to the low read depth obtained
(∼600 reads uniquely aligned on average per sam-
ple, Fig. 5), the CAG frequency distributions obtained
with the PacBio CCS reads were very discontinu-
ous (Fig. 5). This would probably lead to inaccur-
ate estimates of the frequency of these somatic
expansions. Obtaining CAG frequency distributions
with a number of reads an order of magnitude higher
would probably be necessary to more accurately
characterise the inter-tissue differences in somatic
mosaicism [33]. The majority (∼70% for PacBio run
one and ∼95% for PacBio run two) of the PacBio
CCS reads produced for the samples with ∼255
CAGs did not align to a unique reference sequence,
most likely as a function of the within-repeat indels
[49].
Qualitative assessment of the usefulness of
PacBio sequencing to quantify somatic
mosaicism in R6/2 mice with ∼470 CAGs
The percentage of PacBio CCS reads aligned
to a synthetic reference sequence was similar for
samples from both mice with ∼470 CAGs (5.85%
and 7.07% on average for the 6-week-old and the
116-week-old mouse respectively). Strikingly, most
of the aligned PacBio CCS reads contained between
Fig. 5. CAG frequency distributions obtained by PacBio SMRT sequencing of bulk-PCR products obtained for different tissues of one
6-week-old and one 20-week-old R6/2 mouse with ∼255 CAGs. The tail at weaning data for the 20-week-old mouse is not shown because
only two reads with 266 and 274 CAGs were obtained post-alignment and post-discard.
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Fig. 6. CAG frequency distributions obtained by PacBio SMRT sequencing of bulk-PCR products obtained for different tissues of one
6-week-old and one 116-week-old R6/2 mouse with ∼470 CAGs.
100 and 200 CAGs (Fig. 6). This is in stark con-
trast with the CAG repeat distributions previously
obtained on the same DNA samples by both SP-PCR
and bulk-PCR capillary electrophoresis which had
modes ∼500 CAGs (Table 1) [33]. To investigate if
this distribution was caused by the data processing
post-sequencing, we compared the length distribu-
tion of the PCR products before sequencing with
the length distribution of the unprocessed PacBio
subreads and CCS reads. This revealed that most
of the subreads and CCS reads were much shorter
than expected based on the size of the PCR products
produced for PacBio SMRT sequencing of these
samples. Indeed, the estimated modal allele length of
the PCR products was ∼577 CAGs (Supplementary
Figure 4A) while the mode of the subreads and CCS
read length distribution was between 150 and 200
CAGs (Supplementary Figure 4B, C). The skew to-
wards lower (<300) CAG lengths observed in the
frequency distributions obtained from the alignment
of CCS reads (Fig. 6) is thus not caused by the
data processing post-sequencing, but corresponds
to loading and/or sequencing bias towards smaller
fragment on the PacBio RSII sequencing platform.
It must be noted, however, that some PacBio CCS
reads contained >450 CAGs (Fig. 6). To confirm
that PacBio SMRT sequencing was indeed useful to
sequence HTT alleles with ∼500 CAGs, we pooled
all the PacBio CCS reads obtained for all the tissues
considered for each mouse with ∼470 CAGs and
collected all the CCS reads longer than 1,740 nt
(these reads should contain >450 CAGs). This res-
ulted in the collection of 131 and 197 CCS reads
for the 6-week-old and the 116-week-old mouse
respectively. The collected CCS reads were aligned
as described before, except that a single synthetic
reference containing 550 CAGs was used. Of these
reads, 114 out of 131, and 151 out of 197, CCS re-
ads could be aligned to the reference sequence
containing 550 CAGs for the 6-week-old and the
116-week-old mouse respectively. Visualisation of
the alignment using Tablet [46] revealed that most
of the reads obtained from the 6-week-old mouse
contained the full sequence of the PCR product
while most reads obtained from the 116-week-old
mouse contained only one flank (Supplementary
Figure 5). This indicates that the CAG repeat in
these later reads is longer than in the reference
sequence (i.e., 550 CAGs). The presence of germline
interruptions should be clearly identifiable in such
an alignment as shown for DMPK alleles with
∼400 CAG•CTG repeats [30]. Both alignments
clearly showed that both mice with ∼470 CAGs
carried a typical HTT allele with a pure CAG
tract and seven CCGs (i.e., HTT allele of structure
(CAG)n(CAACAG)1(CCGCCA)1(CCG)7(CCT)2
[7]). This thus demonstrates that PacBio SMRT
sequencing of HTT alleles with ∼500 CAGs is
possible.
The PacBio sequencing data illustrates the effect
of the number of inherited CAG repeats on
somatic expansion
Somatic mosaicism of the HTT CAG repeat
depends on age, but also on the number of inher-
ited CAG repeats [7, 8]. An illustration of that effect
can be seen in the PacBio sequencing data obtained
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Fig. 7. Method summary for somatic mosaicism quantification at the level of a single molecule in HD. A) Generalised schematics for
CRISPR/Casp9-mediated targeted enrichment of HTT locus for single-molecule long-read sequencing (i.e., no-amp targeted sequencing).
Following DNA fragmentation and DNA molecule protection by adapter ligation or de-phosphorylation, CRISPR/Cas9 and locus-specific
guide RNAs are used to selectively cut across the region of interest. While undigested DNA fragment ends are still protected, sequencing
adapters are ligated to the Cas9 digestion product. Sequencing is then done on the appropriate single-molecule long-read sequencing platform
such as PacBio SMRT or Oxford Nanopore Technologies (ONT). No-amp targeted sequencing studies of repeat expansions have used one
or two Cas9 cuts with PacBio sequencing [31, 49, 57, 59] or ONT sequencing [58] respectively. Single-molecule sequencing read output
can then be used to build the somatic mosaicism profile. B) The general method for amplicon sequencing of barcoded single molecules.
Several methods for single-molecule barcoding exist, including one-cycle PCR using hairpin-protected primers with degenerate tags or
region capture by barcoded molecular inversion probes. Following barcoding, sequencing adapters are incorporated into the uniquely tagged
molecules through PCR with overhang primers. The resulting amplicon library is then sequenced on the platform of interest, including
Illumina MiSeq or PacBio, depending on the amplicon length and the desired throughput. Resulting reads are grouped by barcode family,
and the repeat length of the original molecule for each family is determined to build the real somatic mosaicism profile per sample.
for the older R6/2 mice analysed, where we can see
more somatic expansions in some samples with a
larger number of inherited CAG repeats. Indeed, we
see a longer tail of more frequent somatic expan-
sions in the cortex and striatum of the mouse with
∼255 CAGs (20-week-old, Fig. 5) compared to the
mouse with∼110 CAGs (20-week-old, Fig. 4). More-
over, despite the older mouse with ∼110 CAGs being
nearly two years younger than the older mouse with
∼55 CAGs, the PacBio sequencing data shows that
there were more somatic expansions in the liver of the
20-week-old mouse with ∼110 CAGs (Fig. 4) than
in the 117-week-old mouse with ∼55 CAGs (Fig. 1).
DISCUSSION
Bulk-PCR sequencing
In the present study, we have applied bulk-PCR
sequencing approaches to sequence HTT CAG repeat
expansions and to quantify the associated somatic
mosaicism. In doing so, we have shown that both
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MiSeq and PacBio technologies can be used to geno-
type the HTT CAG repeat and to quantify somatic
mosaicism. Nevertheless, both sequencing platforms
have limitations. For MiSeq, the main limitation is
read length. In the present study, we have generated
MiSeq sequencing libraries by PCR using a primer in
the immediate 5’–flanking DNA of the CAG repeat.
This, in combination with MiSeq reads of 400 nt, is
expected to limit the sequencing to 123 CAGs. We
have shown that, because of this upper limit, the
MiSeq approach applies to sequencing HTT alleles
containing up to ∼115 CAGs but not to the estimation
of modal allele length of∼110 CAGs and/or the quan-
tification of the somatic mosaicism of such alleles.
Considering this upper limit of 123 CAGs, the largest
modal alleles for which somatic mosaicism will
reliably be quantifiable using bulk-PCR MiSeq are
thus probably ∼90 CAGs. This prediction assumes
that there would be enough leeway between a progen-
itor of ∼90 CAGs and the upper sequencing limit of
123 CAGs to reliably quantify somatic expansions.
We have also shown that the reverse MiSeq reads
allow the determination of the HTT allele structure
(presence/absence, organisation and number of CAA,
CCA, CCG and CCTs 3’ of the CAG repeat) as accu-
rately in samples with ∼110, as in samples with ∼55
CAGs (Supplementary Figure 2). This thus seems to
indicate that the quality of the reverse reads is inde-
pendent of the number of CAGs. It should thus be
possible to use reverse MiSeq reads to determine the
allele structure of any HTT alleles that can be PCR
amplified.
It is unclear whether larger CAG repeat length
and/or inter-run variability inherent to the PacBio
technology is/are responsible for the lower sequenc-
ing quality associated with PacBio run 2 relative to
PacBio run 1 (Supplementary File 2). This difference
in sequencing quality between the two runs warrants
the future use of a sequencing control, similar to the
Illumina PhiX control [50], for PacBio sequencing.
Nevertheless, we have shown that the PacBio plat-
form can be used to sequence HTT alleles of up
to ∼550 CAGs. Based on studies of other unstable
CAG•CTG repeat loci, it is likely possible to sequence
an even higher number of HTT repeats with PacBio
SMRT sequencing. Indeed, Ardui [51] and Hafford-
Tear et al. [31] used PacBio to sequence respectively
DMPK and TCF4 CAG•CTG somatic expansions
containing up to about 1,500 repeats. However, the
bulk-PCR approach we have used in the present study
is not appropriate to estimate the modal number of
CAGs in tissues where it is very large (like the sam-
ples with ∼470 CAGs used in the present study).
Our PacBio data for such samples demonstrate that
the loading/sequencing bias on PacBio RSII SMRT
cells produces CAG frequency distributions biased
towards fragments containing <300 CAGs. This bias
is similar to the one described by Ardui [51] for
the DMPK CAG•CTG repeat where PacBio SMRT
sequencing of bulk-PCR fragments with a mode cor-
responding to ∼750 CAG•CTGs produced reads with
a mode at ∼255 CAG•CTGs. Data presented here
demonstrate, however, that PacBio sequencing would
be useful to quantify somatic mosaicism in individ-
uals with progenitor alleles containing up to ∼250
CAGs.
Comparison of three bulk-PCR approaches with
SP-PCR
The CAG frequency distributions obtained using
bulk-PCR followed by capillary electrophoresis or
MiSeq sequencing for the samples with ∼55 CAGs
were very similar for the smaller and more frequent
somatic expansions (<85 CAGs, Fig. 1). However,
compared to the SP-PCR data, large expansions >90
CAG repeats were underrepresented using the cap-
illary electrophoresis and MiSeq approaches, and
undetectable in the PacBio data (Fig. 3). A major
factor in driving this disparity is the reduced PCR
efficiency in amplifying large alleles compared to
smaller ones. This yields a relatively lower num-
ber of end-products per input molecule for larger
alleles. In SP-PCR, the reduced amplification of
larger alleles is at least partially compensated for
by greater hybridisation efficiency to a repeat unit
probe, and by the spatial resolution offered by the
low number of input molecules, multiple reactions
and gel electrophoresis. That means that the prod-
ucts of single input molecules can still be readily
detected by SP-PCR independent of their size and rel-
ative amplification efficiency (at least up to ∼1,000
repeats). In the capillary electrophoresis approach,
each PCR product contains only a single fluores-
cent moiety incorporated into one of the primers
independent of the size of the molecule. Thus, large
fragments that amplify less efficiently yield a lower
signal. When such larger alleles are relatively rare,
the signal from such molecules becomes lost in the
inevitable background fluorescence observed using
this approach. The sequencing-based approaches do
not yield any inherent background and, as in the
MiSeq data, with high enough read depth (typically
∼45,000 sequencing reads per sample), rare large
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expansions can be detected, albeit at a lower abso-
lute frequency than the relative frequency of input
molecules due to the amplification bias, and proba-
bly a higher frequency of sequencing errors that likely
reduces alignment efficiency too. It seems reason-
able to assume that such large rare expansions would
be similarly detectable with PacBio, assuming read
depth was high enough.
PacBio sequencing produced similar modal allele
estimates to the ones obtained with MiSeq and capil-
lary electrophoresis but showed wider CAG length
frequency distributions. This may be due to the
high frequency of indels in the PacBio subreads whi-
ch may, in turn, lead to an inaccurate number of CAGs
in the CCS reads. Previous PacBio analyses of a DM1
patient carrying a single variant CCG repeat within
their expanded CTG array revealed that this variant
was not detected in 17% of reads, suggesting a possi-
ble issue with CCS read generation [30]. Additional
analyses are required to establish the absolute util-
ity of the CCS pipeline in handling simple sequence
repeats correctly. Nonetheless, like MiSeq and cap-
illary electrophoresis, PacBio sequencing can detect
small frequent somatic expansions and capture some
of the age-dependent and tissue-specific nature of
the somatic mosaicism of the HTT repeat. However,
the lower sequencing depth obtained for the PacBio
CCS reads does not facilitate accurate estimates of the
absolute frequency of somatic expansions. It is likely
that ∼5,000 reads per expanded allele are required to
accurately measure differences in somatic mosaicism
when the variation in CAG lengths is high, as in the
tissues of the older R6/2 mice analysed here. It must
be noted that the R6/2 mice analysed here carried only
one copy of the HTT CAG repeat. When analysing
samples containing both a non-HD-causing and an
HD-causing allele (e.g., samples from human carriers
of HD-causing alleles or knock-in HD animal mod-
els) the read depth obtained for the HD-causing allele
would be expected to be even lower (at least two to
four times lower) due to the preferential PCR ampli-
fication of shorter fragments. The most recent Sequel
II PacBio platform, with an advertised throughput of
up to 4,000,000 CCS reads (∼40X higher than the
RSII platform used in this study, [52]), may over-
come some of the limitations of the low sequencing
depth described in this study (Table 2). However, CCS
reads generated on the Sequel II PacBio platform
would still be expected to contain many within-repeat
indels. Therefore, we expect the issues described
in the present study (i.e., the majority of PacBio
CCS reads being discarded post-alignment because
they align equally well to more than one reference
sequence) to also apply to CCS reads generated on the
Sequel II PacBio platform. Improved bioinformat-
ics methodology, such as an increase in base calling
accuracy [53], the correction of indels [49], the devel-
opment of more indel-tolerant alignment approaches
or alignment-free approaches [49], should benefit the
future analysis of similar sequencing data and facili-
tate greater read depth.
The three bulk-PCR approaches (capillary elec-
trophoresis, MiSeq and PacBio SMRT) share the
same bulk-PCR pitfalls, i.e., lack of detection of very
large and rare expansions that can be detected by
SP-PCR (Fig. 3). The use of bulk-PCR makes the
sequencing library preparation robust and straightfor-
ward, which allows the processing of a high volume
of samples. This is particularly true for the MiSeq
platform, for which the number of reads produced is
much higher than on the PacBio platforms (Table 2).
However, bulk-PCR artefacts make it difficult to esti-
mate the size of larger progenitor alleles, hampering
our ability to quantify somatic expansions very accu-
rately and making it very difficult to quantify somatic
contractions (Table 2).
Future directions in the field for the use of
parallel and single-molecule sequencing
Although strongly biased towards expansion,
somatic instability is thought to involve a combina-
tion of small frequent expansions and contractions
[54]. Contractions of the HTT CAG repeat are
observed in some animal models [33], but virtu-
ally nothing is known about their molecular basis.
A first step to improve our understanding of this
process would be to be able to quantify somatic
repeat contractions. Whereas it is possible to esti-
mate the proportion of somatic expansions using
bulk-PCR, repeat contractions cannot be clearly dis-
tinguished from PCR slippage artefacts and thus
cannot be easily quantified (Table 2). Moreover, as
illustrated here, bulk-PCR fails to identify the rare
large somatic expansions that can be detected using
SP-PCR (Table 2). This is a major problem in the
field, as the pathogenic impact of these rare large
somatic expansions relative to the more frequent
and shorter somatic expansions remains unknown.
Improvement of current methods to detect and quan-
tify repeat contractions and accurately measure the
net frequency of somatic expansions is thus needed.
Such improved methods would expand our under-














Main characteristics of different methods for the preparation of libraries for MiSeq and PacBio for the sequencing of CAG repeats and the quantification of somatic mosaicism
Library Sequencing Max Max Max Estimated Quantity of Indels Relative accuracy Relative accuracy
preparation platform CAG modal somatic sequencing genomic DNA of the quantification of the quantification
repeat CAG expansion cost per required of somatic of somatic
size size∗ size sample∗∗ per sample expansions contractions
Bulk-PCR Illumina MiSeq ∼115 ∼90 ∼120 ∼$8† 20 ng No + not detected if
PacBio RSII ≥550 ∼250 ≥550 ∼$50† 0.1 to 1.2 g Yes + not very large
PacBio Sequel ≥550SM ∼250SM ≥550SM ∼$30† 20 to 240 ngSM Yes +
PacBio Sequel II ≥550SM ∼250SM ≥550SM ∼$10† 20 to 60 ngSM Yes +
SP-PCR Illumina MiSeq ∼115SM ∼90SM ∼120SM ∼$8‡ 2 ngSLM No ++ +
PacBio RSII ≥1500L ≥1200L ≥1500L ∼$50‡ 10 to 120 ngSLM Yes ++ +
PacBio Sequel ≥1500LM ≥1200LM ≥1500LM ∼$30‡ 2 to 24 ngSLM Yes ++ +
PacBio Sequel II ≥1500LM ≥1200LM ≥1500LM ∼$10‡ 2 to 6 ngSLM Yes ++ +
Amplification- Illumina MiSeq ∼115S ∼90S ∼120S ∼$20† ≥5 gL No +++ +++
free PacBio RSII ≥1500L ≥150L ≥1500L ∼$1000† ≥5 gL Yes +++ +++
PacBio Sequel ≥1500LM ≥150LM ≥1500LM ∼$600† ≥5 gL Yes +++ +++
PacBio Sequel II ≥1500LM ≥150LM ≥1500LM ∼$100† ≥5 gL Yes +++ +++
Amplicon Illumina MiSeq ∼115S ∼90S ∼120S ∼$20# 20 to 150 ngL No +++ +++
sequencing PacBio RSII ≥550SM ∼250SM ≥550SM ∼$1000# 2.5 to 30 gSL Yes +++ +++
of barcoded PacBio Sequel ≥550SM ∼250SM ≥550SM ∼$600# 0.4 to 4.8 gSLM Yes +++ +++
single molecules PacBio Sequel II ≥550SM ∼250SM ≥550SM ∼$100# 0.2 to 0.6 gSLM Yes +++ +++
Observations described in this study are indicated in bold, the other information corresponds to expectations for approaches not used in this study based on observations described in this study (S),
on what has been described on other trinucleotide loci in the literature (L) and/or on the manufacturer information available for each sequencing platform (M). ∗: Max modal allele size for which
the modal allele size can be estimated by sequencing and for which somatic mosaicism will reliably be quantified. ∗∗: based on [63]. †: assuming a minimum of ∼5,000 reads per sample and a
maximum of 384 samples per sequencing run. ‡: assuming 20 SP-PCRs per sample and 250 reads per SP-PCRs. #: assuming ∼20 reads per single molecule and the genotyping of 5,000 single
molecules.
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of an individual and the role of somatic instability in
HD disease pathology. More accurately quantifying
the full range of somatic repeat length changes could
also prove useful in identifying genetic modifiers of
somatic instability (it is likely that some variants may
act to modify the size and direction of repeat length
changes, and not just their absolute frequency), and
for the development of outcome measures in clinical
trials that aim to suppress somatic repeat expansions
and/or induce contractions [55].
Some of the limitations of bulk-PCR may be
overcome by using recombinase polymerase ampli-
fication, an isothermal replacement to PCR that has
been shown to produce fewer HTT CAG slippage pr-
oducts [56], or SP-PCR-sequencing which has the
potential of allowing the detection of rare large
somatic expansions [51]. However, these approaches
are still limited to some extent by PCR slippage, con-
founding the quantification of somatic contractions
(Table 2). Using amplification-free methods should
allow detection and accurate quantification of both
somatic contractions and large somatic expansions
that remain undetectable using bulk-PCR (Table 2).
Such an amplification-free approach for sequenc-
ing of repeat-expansion loci has been developed
by Tsai et al. [57]. This approach, named “no-amp
targeted sequencing”, utilises the capture and enrich-
ment of the region(s) of interest using the CRI
SPR/Cas9 system (Fig. 7A). In trinucleotide expan-
sion studies, no-amp targeted sequencing has so far
been used in combination with PacBio or Oxford
Nanopore Technologies (ONT) long-read single-
molecule sequencing [31, 49, 57–59]. This is because
the size of the repeat expansion of interest was
expected to be very large [31, 58, 59] but also be-
cause the captured fragments are typically several
kilobases long [49, 57]. Hafford-Tear et al. [31] have
demonstrated that no-amp targeted PacBio SMRT
sequencing can capture somatic mosaicism by show-
ing that the variance in the number of repeats
increases with the modal number of CAG•CTG in
the third intron of TCF4. The application of no-amp
targeted PacBio SMRT sequencing to two fully-
penetrant HD-causing alleles (>39 CAGs) suggested
that no-amp targeted sequencing might be useful
to quantify somatic mosaicism at the HTT repeat
[49]. However, Höijer et al.’s [49] no-amp HTT
PacBio SMRT sequencing data contains frequent
intra-individual variation in the number of CAGs
associated with the non-HD-causing allele. Because
somatic instability of non-HD-causing alleles has not
been described before, this is very unexpected. Such
variation is, therefore, likely to have been generated
by a technical and/or data processing bias and should
be investigated to validate the approach for studying
the somatic instability of the HTT repeat. Moreover,
the CRISPR/Cas9 capture efficiency was not 100%
specific to the HTT locus and was associated with a
very large fraction of off-target reads (∼95%) [49].
This, together with the fact that Höijer et al. [49] also
targeted C9orf72, ATXN10 and FMR1, contributed
to a very limited sequencing depth of the HTT repeat
(157 HTT repeat reads per sample on average and
only 32 reads for each for the two fully-penetrant HD-
causing alleles). At that low read depth, the precision
in the estimation of the frequency of somatic vari-
ants is low. For example, the estimated percentage
of somatic expansions estimated was 21.88% with
a 95% confidence ranging from 9.28 to 39.97% and
53.13% with a 95% confidence ranging from 34.74 to
70.91% for the two fully-penetrant HD-causing alle-
les analysed by no-amp HTT PacBio sequencing [49].
No-amp PacBio SMRT sequencing of the HTT repeat
thus needs major improvements (reduction of the off-
target capture and evaluation of technical artefacts) to
be useful in HD research focused on somatic insta-
bility of the HTT repeat. Assuming that the HTT read
depth would quadruple if Höijer et al.’s [49] no-amp
PacBio SMRT was made HTT-specific (because the
published data correspond to an assay where HTT was
one of four loci targeted), the most recent Sequel II
PacBio platform should theoretically produce 10,000
CCS reads per sample if sequencing ∼25 samples per
Sequel II PacBio SMRT cell. Such a read depth per
sample should allow accurate quantification of the
frequency of somatic HTT CAG variants.
No-amp targeted ONT (Oxford Nanopore Tech-
nologies) sequencing has so far only been applied to
cell line DNA to sequence the C9orf72 GGGGCC
and the FMR1 CGG repeats [58]. Its usefulness to
estimate somatic mosaicism of the HTT repeat from
primary tissue samples thus remains to be demon-
strated. Nevertheless, the high error rate of ONT
sequencing, including insertion and deletion errors,
stands as an obstacle in obtaining sequence informa-
tion for repeated DNA with the accuracy required
for the quantification of somatic mosaicism, at least
through conventional alignment-based pipelines.
Alignment-free raw-read signal processing algo-
rithms were shown to improve the suitability of ONT
for genotyping long repeated DNA regions [58, 60]
but are still prone to technical errors even when pro-
cessing reads from short repeat regions. For example,
Liu et al. [60] obtained very broad CAG frequency
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distributions for non-disease associated alleles at the
ATXN3 CAG repeat. This suggests that this type
of ONT application would not be appropriate for
the quantification of somatic mosaicism of small
CAG•CTG expansions, although it might be suffi-
cient for estimating the modal number of CAG•CTGs.
Sequencing library preparation techniques, that allow
the sequencing of the same starting molecule multiple
times using a single ONT read, have been proposed
to generate more accurate ONT consensus sequenc-
ing reads (conceptually similar to PacBio CCS reads)
[61, 62]. In the future, these ONT consensus sequenc-
ing reads might prove more useful than standard
ONT reads for the accurate quantification of somatic
mosaicism of CAG•CTG expansions.
The no-amp targeted long-read sequencing
approaches published so far [31, 49, 57–59] are of
great utility to sequence and size very large repeat
expansions (3,000 repeats at some loci in some
tissues) that are refractory to PCR and can only be
assessed by relatively crude Southern blot analysis
of restriction digested genomic DNA, or that can
only be detected by SP-PCR. However, they have
several major limitations that make them unsuitable,
in their current form, for high-throughput analysis
of low levels of variation and for modifier studies
that require the analysis of large cohorts. Indeed,
they require micrograms of DNA (Table 2) and pro-
duce low numbers of reads (∼5,000 on target PacBio
CCS reads per RSII SMRT cell [49] and < 1,000 on
target ONT reads per MinION flow cell [58]) at a
high cost (assuming a best-case scenario of 5% on-
target reads and the production of 4,000,000 PacBio
CCS reads on one Sequel II SMRT cell, the sequenc-
ing cost would be ∼$100 per sample (Table 2) [63]
with a requirement of 5,000 reads per sample to
quantify somatic mosaicism). MiSeq sequencing-
based methods, that offer higher throughput, remain
more cost-effective for routinely quantifying somatic
mosaicism in primary tissue samples from individ-
uals having inherited HD-causing alleles with <100
CAGs (sequencing cost would be ∼$8 per sample
(Table 2) [63] if producing 40,000 MiSeq reads per
sample and processing 380 samples per MiSeq run).
Another potential route for quantifying somatic
mosaicism that reduces some of the limitations of
bulk-PCR is to use single-molecule DNA barcoding
in combination with PCR. Through this approach,
one can trace the sequence reads back to a sin-
gle input molecule which allows the identification
of PCR and sequencing errors. In the context of a
repeated sequence, such an approach can be used to
correct for PCR slippage and identify the repeat size
in the original molecule (Fig. 7B) [64]. Besides, this
approach should also, at least partially, correct for the
PCR amplification efficiency problem that generates
relatively fewer yields per input molecule for larger
alleles. Several methods have been developed to
achieve single-molecule barcoding, including molec-
ular inversion probe (MIP) capture using probes with
degenerate tags and one- to three-cycle PCR using
barcoded primers at low concentrations [65, 66]. Such
methods, combined with high-throughput sequenc-
ing, allow multiplexing across loci in large cohorts
while providing single-molecule level sequence data.
Single-molecule barcoding has been mostly explored
in human tumour sequencing analysis and was shown
to perform very well in detecting single-base somatic
variants at an allele frequency of <0.5% [65, 66]. With
a primary focus on single nucleotide variants, vari-
ation in microsatellite regions has been somewhat
less well explored to date, but with some evidence
showing that, for example, MIP capture is less effi-
cient for repeat regions when compared to single
base variation in multi-loci capture assays [67]. How-
ever, single-molecule barcoding by MIP capture was
recently shown to be a sensitive method in detecting
repeat length variants, including repeat contractions,
across multiple microsatellite loci in A. thaliana
[64]. This suggests that this approach should be
applicable to human microsatellites. The main disad-
vantage of such barcoding methods, when compared
to amplification-free sequencing library preparation,
is that DNA molecules are copied by polymerase
during the barcoding step; thus, any insertion and
deletion errors that occur during this stage are indis-
tinguishable from true somatic variants. However,
preliminary data suggest that such errors, at least
in MIP capture, form background noise that does
not disrupt genotype calling [64]. With relatively
low amounts of the input DNA required and high-
order multiplexing potential, amplicon sequencing of
barcoded single molecules offers a potentially cost-
effective solution for quantifying somatic mosaicism
for moderate CAG expansions in HTT and could be
adapted to long alleles by using long-read sequencing
platforms such as PacBio (Table 2).
ACKNOWLEDGMENTS
The authors wish to thank the D.G.M. group for
helpful advice with this work and David Meltzer,
David McGuinness and Julie Galbraith, from Glas-
gow Polyomics, for administrating the Galaxy
72 M. Ciosi et al. / Sequencing of HTT CAG Expansions
instance of the University of Glasgow (D.M. &
D.McG.) and for their help and insight with the MiSeq
sequencing (J.G. and D.McG.). This work was sup-
ported by the CHDI Foundation (awards to D.G.M.
and A.J.M.) and the National Institutes of Health
USA (Grants Nos. R01NS049206 to V.C.W.).
CONFLICT OF INTEREST
V.C.W. is a scientific advisory board member of
Triplet Therapeutics, a company developing new
therapeutic approaches to address triplet repeat dis-
orders such as HD and myotonic dystrophy and
of LoQus23 Therapeutics, and has provided paid
consulting services to Alnylam. Her financial inter-
ests in Triplet Therapeutics were reviewed and are
managed by Massachusetts General Hospital and
Partners HealthCare in accordance with their con-
flict of interest policies. S.K. is employed by CHDI
Management, Inc., as an advisor to the CHDI Foun-
dation. D.G.M. has been a scientific consultant and/or
received honoraria or stock options from Biogen
Idec, AMO Pharma, Charles River, Vertex Pharma-
ceuticals, Triplet Therapeutics, LoQus23, and Small
Molecule RNA and has had research contracts with
AMO Pharma and Vertex Pharmaceuticals.
SUPPLEMENTARY MATERIAL
The supplementary material is available in the
electronic version of this article: https://dx.doi.org/
10.3233/JHD200433.
REFERENCES
[1] Aziz NA, van der Burg JMM, Tabrizi SJ, Landwehrmeyer
GB. Overlap between age-at-onset and disease-progres-
ion determinants in Huntington disease. Neurology.
2018;90(24):e2099-e106. doi: 10.1212/wnl.00000000000
05690
[2] Donaldson J, Powell S, Rickards N, Holmans P, Jones L.
What is the pathogenic CAG expansion length in Hunt-
ington’s disease? J Huntingtons Dis. 2020;doi: 10.3233/
JHD-200445
[3] Hong EP, MacDonald ME, Wheeler VC, Jones L, Hol-
mans P, Orthe M, et al. Huntington’s disease pathogenesis:
Two sequential components. J Huntingtons Dis. 2020;doi:
10.3233/JHD-200427
[4] Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti
F, Frontali M, et al. Trinucleotide repeat length instabil-
ity and age of onset in Huntington’s disease. Nat Genet.
1993;4(4):387-92. doi: 10.1038/ng0893-387
[5] Monckton DG. Somatic expansion of the CAG repeat in
Huntington disease: An historical perspective. J Hunting-
tons Dis. 2020;doi: 10.3233/JHD-200429
[6] Shelbourne PF, Keller-McGandy C, Bi WL, Yoon SR,
Dubeau L, Veitch NJ, et al. Triplet repeat mutation length
gains correlate with cell-type specific vulnerability in
Huntington disease brain. Hum Mol Genet. 2007;16(10):
1133-42. doi: 10.1093/hmg/ddm054
[7] Ciosi M, Maxwell A, Cumming SA, Hensman Moss DJ,
Alshammari AM, Flower MD, et al. A genetic associa-
tion study of glutamine-encoding DNA sequence structures,
somatic CAG expansion, and DNA repair gene variants,
with Huntington disease clinical outcomes. EBioMedicine.
2019;48:568-80. doi: 10.1016/j.ebiom.2019.09.020
[8] Veitch NJ, Ennis M, McAbney JP, Shelbourne PF,
Monckton DG. Inherited CAG·CTG allele length is a
major modifier of somatic mutation length variability in
Huntington disease. DNA repair. 2007;6(6):789-96. doi:
10.1016/j.dnarep.2007.01.002
[9] Kennedy L, Evans E, Chen CM, Craven L, Detloff PJ,
Ennis M, et al. Dramatic tissue-specific mutation length
increases are an early molecular event in Huntington dis-
ease pathogenesis. Hum Mol Genet. 2003;12(24):3359-67.
doi: 10.1093/hmg/ddg352
[10] Mouro Pinto R, Arning L, Giordano JV, Razghandi P,
Andrew MA, Gillis T, et al. Patterns of CAG repeat
instability in the central nervous system and periphery in
Huntington’s disease and in spinocerebellar ataxia type
1. Hum Mol Genet. 2020;29(15):2551-67. doi: 10.1093/
hmg/ddaa139
[11] Telenius H, Kremer B, Goldberg YP, Theilmann J, Andrew
SE, Zeisler J, et al. Somatic and gonadal mosaicism of
the Huntington disease gene CAG repeat in brain and sperm.
Nat Genet. 1994;6(4):409-14. doi: 10.1038/ng0494-409
[12] Wheeler V, Dion V. Modifiers of CAG repeat instability:
Insights from model systems. J Huntingtons Dis. 2020;doi:
10.3233/JHD-200426
[13] Reiner A, Dragatsis I, Dietrich P. Genetics and neu-
ropathology of Huntington’s disease. Int Rev Neuro-
biol. 2011;98:325-72. doi: 10.1016/B978-0-12-381328-
2.00014-6
[14] Swami M, Hendricks AE, Gillis T, Massood T, Mysore J,
Myers RH, et al. Somatic expansion of the Huntington’s
disease CAG repeat in the brain is associated with an earlier
age of disease onset. Hum Mol Genet. 2009;18(16):3039-
47. doi: 10.1093/hmg/ddp242
[15] Flower M, Lomeikaite V, Ciosi M, Cumming S, Morales F,
Lo K, et al. MSH3 modifies somatic instability and disease
severity in Huntington’s and myotonic dystrophy type 1.
Brain. 2019;142(7):1876-86. doi: 10.1093/brain/awz115
[16] Genetic Modifiers of Huntington’s Disease (GeM-HD)
Consortium. CAG repeat not polyglutamine length deter-
mines timing of Huntington’s disease onset. Cell. 2019;
178(4):887-900.e14. doi: 10.1016/j.cell.2019.06.036
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